Europe Pharmaceutical Packaging Market

The European pharmaceutical packaging market is projected to reach USD 95.78 billion in 2030 from USD 49.24 billion in 2025, at a CAGR of 14.2% during the forecast period.

The European Pharmaceutical Packaging reports a growth in demand for packaging that is safe, convenient, and sustainable through advances in various technologies. An elevated level of regulatory compliance regarding product safety and efficacy is demanding that packaging technology manufacturers provide solutions through innovative products and services. Examples include, but are not limited to, Pre-filled Syringes, Child-Resistant Closures (CRCs), Tamper-Evident Packaging Formats (TEPF), and Smart Packaging. Manufacturers will provide new opportunities for growth to pharmaceutical firms that use sustainable and recyclable materials by providing manufacturers with an opportunity to continue to meet their global sustainability goals by co-operating with supply chain partners with similar goals. The introduction of innovative packaging solutions such as unit dose packaging, digital-enabled tracking systems, and the continual development of barrier properties to enhance drug stability will play a significant role in shaping the future direction of the packaging space. The major pharmaceutical packaging players that account for a significant portion of the market include Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Nolato AB (Sweden), and Smurfit Westrock (Ireland). These companies promote competition through product innovation, growth initiatives, partnerships, and mergers, and emphasize customized packaging solutions to meet the varied pharmaceutical needs. Though the top five companies have only a modest share of the global market, their large scale and high levels of R&D mean that they are a major player in the industry. Additionally, many regional and niche players continue to add to market fragmentation and increased competition, creating options for pharmaceutical manufacturers worldwide.

To know about the assumptions considered for the study download the pdf brochure

Amcor plc is a leading packaging company for food, beverage, pharmaceutical, medical, home & personal care, and other products. It is primarily involved in the manufacturing and marketing of flexible packaging, rigid containers, and specialty cartons and closures by using raw materials such as polymers, aluminum foils, and fibers. Amcor PLO operates a substantial global network of manufacturing and support facilities across its two main segments: Flexibles and Rigid Packaging. With 36 countries housing 160 major operations, the Flexibles segment is made up of 111 owned and 49 leased (or rented) from outside sources. Each of those properties typically has lease terms initially ranging from 2 to 36 years and often includes one or more renewal options. In comparison, the Rigid Packaging segment includes 52 significant facilities across 11 countries, with a smaller proportion owned directly by the company-12 facilities-while the remaining 40 are leased. Lease periods for the Rigid Packaging facilities are typically between 2-20 years, with many containing renewal options, which further shows the Flexibles segment has the largest worldwide presence, and also holds a much larger percentage of its property in owned facilities than does the Rigid Packaging segment, which is primarily dependent upon leasing. Amcor plc has a wide range of healthcare packaging for oral, dermal, medical devices, hospital packaging, ophthalmic & vision care, pulmonary, intravenous fluid, and injectables. It performs its operations through subsidiaries in the EMEA (Europe, the Middle East, and Africa), the Americas, and Asia Pacific. The company operates through 212 production sites in more than 40 countries.

Gerresheimer AG is a well-recognized leader in the pharma and healthcare packaging and systems in Europe. With production sites in Europe, North and South America, and Asia, Gerresheimer develops and produces primary packaging solutions from glass and plastic for medicines, diagnostics, and cosmetics. Gerresheimer has three operating divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies, with pharmaceutical packaging existing mainly in the two former business units. Gerresheimer has a worldwide manufacturing presence, including 36 production sites in 15 countries-Germany, Belgium, France, Spain, Denmark, Switzerland, Poland, the Czech Republic, North Macedonia, Mexico, Brazil, the US, India, China, and Singapore-to maintain the company close to the major pharma hubs and customers. Offering a broad product range, from vials, ampuls, and syringes to complex drug-delivery devices.

Schott AG manufactures high-tech materials for specialty glasses. The company operates as a subsidiary of Carl-Zeiss-Stiftung (Germany). It operates through precision materials, optical industries, home appliances, and trade & others. The packaging business is conducted through its precision materials business division. Schott AG serves numerous industries, including healthcare, home appliances & living, consumer electronics, semiconductors & datacom, optics, industry & energy, automotive, and astronomy & aerospace. Schott established its subsidiary, Schott Pharma, to advance its growth strategy for its pharma business, particularly in drug containment and delivery solutions. Schott Pharma’s product line includes drug containment options to drug delivery systems, such as pharmaceutical syringes, cartridges, vials, and ampoules, with over 13 billion drug containers produced yearly. Schott AG offers glass tubing and primary packaging, including syringes, vials, ampoules, and cartridges for the pharmaceutical industry. Schott has manufacturing sites and sales offices in 34 countries and 600 production sites in 13 countries. The company has 17,400 employees worldwide.

Nolato AB is a Swedish, publicly listed polymer solutions company that supplies the pharmaceutical and medical technology industries with high-quality primary plastic packaging. Within its Medical Solutions business, Nolato designs and manufactures packaging, including bottles, containers, caps, and closures, with strong expertise in child-resistant and tamper-evident systems and in low-moisture-permeation designs suited for sensitive drug formulations. Through specialist units such as Nolato Cerbo (Sweden) and Nolato Jaycare (UK), the company combines advanced injection and injection-blow molding, cleanroom manufacturing, and GMP-aligned traceability to support both prescription and over-the-counter medicines. Nolato’s pharmaceutical packaging portfolio is built around patient safety, regulatory compliance, and design-for-manufacture, with increasing integration of sustainability-driven material choices and lifecycle considerations for global pharmaceutical customers.

Smurfit WestRock, headquartered in Ireland, is a leading global player in paper-based packaging following its merger with Smurfit Kappa. It supplies a full range of secondary pharmaceutical packaging and medication management solutions not only to Europe but also worldwide. The health and pharma division of the company is capable of offering a wide range of products, such as folding cartons, printed cartons, labels, leaflets, tamper-evident and child-resistant packs, as well as clinical, trial, and patient adherence packaging systems that are designed to meet the most stringent regulatory and patient use requirements. Smurfit Westrock assists pharmaceutical companies by providing design, printing, security features, and supply chain improvements, thus allowing brand communication, compliance, and drug protection at every stage of the medicine lifecycle. Besides that, the company is very much into using renewable and recyclable materials and has, therefore, financially backed the construction of separate, GMP-compliant clinical and adherence packaging facilities in Europe. This is a clear indication of how Smurfit Westrock is working to cement its position as a full-service partner to the regulated pharmaceutical packaging industry.

MARKET RANKING

The Europe pharmaceutical packaging market is fragmented, with the leading five companies, Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Nolato AB (Sweden), and Smurfit Westrock (Ireland) accounting for around 12–15% of the global market share. These companies sustain their market leadership by offering a full range of primary, secondary, and tertiary pharmaceutical packaging while innovating with sustainable materials and drug-delivery formats focused on patients. Their strategic investments, compliance with government regulations, and expansion into new markets will remain their areas of concentration in order to solidify their market position and address growing demand for safe and effective drug packaging solutions.

Related Reports:

Europe Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com